National Taiwan University Hospital
Taipei, Taiwan
NCT Number: NCT01758354
The purpose of this study is to test the feasibility of a newborn screen assay for Pompe disease
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Taipei, Taiwan
DBS from newborn will be tested for acid alpha-glucosidase (GAA) activity. Babies with low GAA activity will be confirmed for Pompe disease.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
DBS will be tested for acid alpha-glucosidase (GAA)activity. Newborns with low GAA activity will received a confirmatory blood sampling and clinical evaluation for the presence of cardiomyopathy.
Time frame: 3 months
National Taiwan University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03533673
Brain Diseases, Brain Diseases, Metabolic
Durham, North Carolina, United States
View Trial DetailsNCT02675465
Brain Diseases, Brain Diseases, Metabolic
Phoenix, Arizona, United States
View Trial DetailsNCT05687474
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
Liège, Wallonia, Belgium
View Trial DetailsNCT01380743
Brain Diseases, Brain Diseases, Metabolic
Phoenix, Arizona, United States
View Trial Details